Remove 2015 Remove Clinical Development Remove Pharma Companies Remove Small Molecule
article thumbnail

BioSpace Global Roundup, Oct. 15

The Pharma Data

Priothera will use the funds to progress the clinical development of mocravimod, a modulator of sphingosine 1 phosphate (S1P) receptors, to enhance the curative potential of allogeneic hematopoietic stem cell transplantation (HSCT) for treating AML. Dolmatics – U.K.-based based Dotmatics Ltd.